This paper is only available as a PDF. To read, Please Download here.
Abstract
The United States Pharmacopeia (USP) Practitioners' Reporting Network utilized nearly
three decades of experience to design and develop a nationwide, anonymous, Internet-accessible
service for hospitals to report and benchmark medication errors (also known as “preventable
adverse drug events”). As nationwide experiential reporting enters the 21st century,
the features of MedMARx™ will provide facilities with the unprecedented ability to
conduct daily continuous quality improvement that encompasses medication error risk
analysis and prevention based on the experiences of other facilities. Data elements
were developed based on review by expert panels and USP's experience with the Medication
Errors Reporting Program. The success of this model could indicate its usefulness
in other practice settings and for broader applications in health care.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Incidence of adverse drug events and potential adverse drug events: Implications for prevention.JAMA. 1995; 274: 29-34
Article info
Identification
Copyright
© 1998 Published by Elsevier Inc.
